Literature DB >> 388954

On the different response of Salmonella typhimurium hisG46 and TA1530 to mutagenic action of base analogues.

C Janion.   

Abstract

Various mutagens are known to induce more his+ revertants in TA1530 than in hisG46 strain. To test whether the mutator effect shown by TA1530 is limited to the his mutation, the lysA8 marker was introduced into both the TA1530 and hisG46 strain, and its reversibility, after induction by N4-hydroxycytidine, was estimated. The ability to reverse the lys marker was tenfold higher in the TA1530/lysA8 transductants than in the hisG46/lysA8 transductants or in the donor for lys, the lysA8 strain.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 388954

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  4 in total

1.  Hypersensitivity of Escherichia coli Delta(uvrB-bio) mutants to 6-hydroxylaminopurine and other base analogs is due to a defect in molybdenum cofactor biosynthesis.

Authors:  S G Kozmin; Y I Pavlov; R L Dunn; R M Schaaper
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

2.  YcbX and yiiM, two novel determinants for resistance of Escherichia coli to N-hydroxylated base analogues.

Authors:  Stanislav G Kozmin; Prune Leroy; Youri I Pavlov; Roel M Schaaper
Journal:  Mol Microbiol       Date:  2008-02-26       Impact factor: 3.501

3.  Molybdenum cofactor-dependent resistance to N-hydroxylated base analogs in Escherichia coli is independent of MobA function.

Authors:  Stanislav G Kozmin; Roel M Schaaper
Journal:  Mutat Res       Date:  2007-02-02       Impact factor: 2.433

4.  Optimization of 2-Aminoquinazolin-4-(3H)-one Derivatives as Potent Inhibitors of SARS-CoV-2: Improved Synthesis and Pharmacokinetic Properties.

Authors:  Young Sup Shin; Jun Young Lee; Sangeun Jeon; Jung-Eun Cho; Subeen Myung; Min Seong Jang; Seungtaek Kim; Jong Hwan Song; Hyoung Rae Kim; Hyeung-Geun Park; Lak Shin Jeong; Chul Min Park
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.